Home

snížit zpět magie Koncentrace event free survival overall Obohacení Súdán sklenka

Enrolling children with acute lymphoblastic leukaemia on a clinical trial  improves event-free survival: a population-based study | British Journal of  Cancer
Enrolling children with acute lymphoblastic leukaemia on a clinical trial improves event-free survival: a population-based study | British Journal of Cancer

Improved Event-Free Survival and Higher Incidence of Early Fever Associated  with Mismatches at HLA-DRB1 after Nonmyeloablative HLA-Haploidentical  Transplantation - Biology of Blood and Marrow Transplantation
Improved Event-Free Survival and Higher Incidence of Early Fever Associated with Mismatches at HLA-DRB1 after Nonmyeloablative HLA-Haploidentical Transplantation - Biology of Blood and Marrow Transplantation

Kaplan-Meier curve for overall survival (OS) and event-free survival (EFS)  according to the expression of CD30 and treatment.
Kaplan-Meier curve for overall survival (OS) and event-free survival (EFS) according to the expression of CD30 and treatment.

ASH 2022: FLAG-Ida Combined with Gemtuzumab Ozogamicin (GO) Improves Event  Free Survival in Younger Patients with Newly Diagnosed Acute Myeloid  Leukaemia (AML) and Shows an Overall Survival Benefit in NPM1 and FLT3
ASH 2022: FLAG-Ida Combined with Gemtuzumab Ozogamicin (GO) Improves Event Free Survival in Younger Patients with Newly Diagnosed Acute Myeloid Leukaemia (AML) and Shows an Overall Survival Benefit in NPM1 and FLT3

Event-free survival at 24 months is a robust surrogate endpoint for  long-term survival in pediatric, adolescent, and adult T cell lymphoblastic  lymphoma | SpringerLink
Event-free survival at 24 months is a robust surrogate endpoint for long-term survival in pediatric, adolescent, and adult T cell lymphoblastic lymphoma | SpringerLink

Frontiers | Evaluation of Event-Free Survival Surrogating Overall Survival  as the Endpoint in Neoadjuvant Clinical Trials of Gastroesophageal  Adenocarcinoma
Frontiers | Evaluation of Event-Free Survival Surrogating Overall Survival as the Endpoint in Neoadjuvant Clinical Trials of Gastroesophageal Adenocarcinoma

Relationship between presarcopenia and event occurrence in patients with  primary hepatocellular carcinoma | Scientific Reports
Relationship between presarcopenia and event occurrence in patients with primary hepatocellular carcinoma | Scientific Reports

A prognostic nomogram for event-free survival in patients with atrial  fibrillation before cardiac resynchronization therapy | BMC Cardiovascular  Disorders | Full Text
A prognostic nomogram for event-free survival in patients with atrial fibrillation before cardiac resynchronization therapy | BMC Cardiovascular Disorders | Full Text

Relationship between event-free survival and overall survival in acute  myeloid leukemia: a report from SWOG, HOVON/SAKK, and MRC/NCRI |  Haematologica
Relationship between event-free survival and overall survival in acute myeloid leukemia: a report from SWOG, HOVON/SAKK, and MRC/NCRI | Haematologica

MicroRNA‑181b‑5p insufficiency predicts treatment response failure risk and  unfavorable event‑free survival as well as overall survival in acute  myeloid leukemia patients
MicroRNA‑181b‑5p insufficiency predicts treatment response failure risk and unfavorable event‑free survival as well as overall survival in acute myeloid leukemia patients

Event-free survival > Overall survival? - data analysis - Datamethods  Discussion Forum
Event-free survival > Overall survival? - data analysis - Datamethods Discussion Forum

Six-Year Natural History Comparison with Mirum's LIVMARLI (maralixibat)  Demonstrates Event-Free Survival and Transplant-Free Survival in Patients  with Alagille Syndrome | Business Wire
Six-Year Natural History Comparison with Mirum's LIVMARLI (maralixibat) Demonstrates Event-Free Survival and Transplant-Free Survival in Patients with Alagille Syndrome | Business Wire

A correlation analysis to assess event-free survival as a trial-level  surrogate for overall survival in early breast cancer - eClinicalMedicine
A correlation analysis to assess event-free survival as a trial-level surrogate for overall survival in early breast cancer - eClinicalMedicine

Event-free survival curves. The Kaplan-Meier curves demonstrate no... |  Download Scientific Diagram
Event-free survival curves. The Kaplan-Meier curves demonstrate no... | Download Scientific Diagram

A correlation analysis to assess event-free survival as a trial-level  surrogate for overall survival in early breast cancer - eClinicalMedicine
A correlation analysis to assess event-free survival as a trial-level surrogate for overall survival in early breast cancer - eClinicalMedicine

Kaplan-Meier survival analysis
Kaplan-Meier survival analysis

Event-free Survival with Pembrolizumab in Early Triple-Negative Breast  Cancer | NEJM
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer | NEJM

View Image
View Image

Response Rate, Event-Free Survival, and Overall Survival in Newly Diagnosed  Acute Myeloid Leukemia: US Food and Drug Administration Trial-Level and  Patient-Level Analyses | Journal of Clinical Oncology
Response Rate, Event-Free Survival, and Overall Survival in Newly Diagnosed Acute Myeloid Leukemia: US Food and Drug Administration Trial-Level and Patient-Level Analyses | Journal of Clinical Oncology

OP0294 SJÖGREN'S SYNDROME ASSOCIATED LYMPHOMAS: CLINICAL DESCRIPTION AND  10-YEAR SURVIVAL | Annals of the Rheumatic Diseases
OP0294 SJÖGREN'S SYNDROME ASSOCIATED LYMPHOMAS: CLINICAL DESCRIPTION AND 10-YEAR SURVIVAL | Annals of the Rheumatic Diseases

Disease Free Survival - an overview | ScienceDirect Topics
Disease Free Survival - an overview | ScienceDirect Topics

Statistical considerations and endpoints for clinical lung cancer studies:  Can progression free survival (PFS) substitute overall survival (OS) as a  valid endpoint in clinical trials for advanced non-small-cell lung cancer?  | Semantic
Statistical considerations and endpoints for clinical lung cancer studies: Can progression free survival (PFS) substitute overall survival (OS) as a valid endpoint in clinical trials for advanced non-small-cell lung cancer? | Semantic

Blood and tissue biomarker analysis in dogs with osteosarcoma treated with  palliative radiation and intra-tumoral autologous natural killer cell  transfer | PLOS ONE
Blood and tissue biomarker analysis in dogs with osteosarcoma treated with palliative radiation and intra-tumoral autologous natural killer cell transfer | PLOS ONE

Prognostic Index for Predicting Overall Survival and Event-Free Survival In  Total Therapy 3 Patients - ScienceDirect
Prognostic Index for Predicting Overall Survival and Event-Free Survival In Total Therapy 3 Patients - ScienceDirect

Fig. 72.1, [Four-year event-free survival (EFS), overall...]. - The EBMT  Handbook - NCBI Bookshelf
Fig. 72.1, [Four-year event-free survival (EFS), overall...]. - The EBMT Handbook - NCBI Bookshelf

Event-free Survival with Pembrolizumab in Early Triple-Negative Breast  Cancer | NEJM
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer | NEJM